Cited by 284Neurofibromatosis and Schwannoma CasesProtein Tyrosine PhosphatasesAcute Myeloid Leukemia Research

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Nf1 deficiency causes Ras-Dediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

Largaespada, David A., Brannan, Camilynn I., Jenkins, Nancy A., Copeland, Neal G.·1996·Nature Genetics

Open this paper in CoChat — free account

Abstract

The Ras signal transduction pathway is often deregulated in human myeloid leukaemia. For example, activating point mutations in RAS genes are found in some patients with juvenile chronic myelogenous leukaemia (JCML), while other patients with JCML show loss of the neurofibromatosis type 1 (NF1) gene, a Ras GTPase activating protein. By generating mice whose haematopoietic system is reconsituted with Nf1 deficient haematopoietic stem cells we show that Nf1 gene loss, by itself, is sufficient to produce the myeloproliferative symptoms associated with human JCML. We also provide evidence to indicate that Nf1 gene loss induces myeloproliferative disease through a Ras-mediated hypersensitivity to granulocyte/macrophage-colony stimulating factor (GM-CSF). Finally, we describe a genetic screen for identifying genes that cooperate with Nf1 gene loss during progression to acute myeloid leukaemia.

Integrity signals

Registry

Crossref · 10.1038/ng0296-137

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neurofibromatosis, Phenotype, Natural History, and Pathogenesis
Riccardi, V. M., & Smirniotopoulos, J. G. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199211000-00009 · Cited by 897
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1
Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., & Weinberg, R. A. (1994) · Nature Genetics · doi:10.1038/ng0794-353 · Cited by 780
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., & Downward, J. (1992) · Nature · doi:10.1038/356713a0 · Cited by 669
BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein
Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80094-7 · Cited by 657
Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.
Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., & Copeland, N. G. (1994) · Genes & Development · doi:10.1101/gad.8.9.1019 · Cited by 641
Self-citation
Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
DeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C., & Lowy, D. R. (1992) · Cell · doi:10.1016/0092-8674(92)90407-4 · Cited by 580
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells
Hestdal, K., Ruscetti, F. W., Ihle, J. N., Jacobsen, S. E. W., Dubois, C. M., Kopp, W. C., Longo, D., & Keller, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.22 · Cited by 464
Loss of The Normal NF1 Allele from the Bone Marrow of Children with Type 1 Neurofibromatosis and Malignant Myeloid Disorders
Shannon, K., O'Connell, P., Martin, G. A., Paderanga, D., Olson, K., Dinndorf, P. A., & McCormick, F. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300903 · Cited by 440
Bcr‐Abl oncoproteins bind directly to activators of the Ras signalling pathway.
Puil, L. J., Liu, J., Gish, G., Mbamalu, G., Bowtell, D. D. L., Pelicci, P. G., Arlinghaus, R. B., & Pawson, T. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06319.x · Cited by 438
Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5
Miyajima, A., Mui, A. L.-F., Ogorochi, T., & Sakamaki, K. (1993) · Blood · doi:10.1182/blood.v82.7.1960.bloodjournal8271960 · Cited by 414

Flagged first, then by citations

Show all 33 references

Research works printed but not linked: 2

Hope, D.G. & Mulvihill, J.J. Malignancy in neunofibromatosis. Adv. Neurol. 29, 33–56 (1981).
Gonda, T.J. Molecular and cellular activities of Myb: regulation in normal hemopoiesis and transformation. Seminars in virology 2, 351–361 (1991).

Sorted by citations

Items 201–284 of 284

Signaling revisited in acute promyelocytic leukemia
Lutz, P. G., Moog‐Lutz, C., & Cayre, Y. (2002) · Leukemia · doi:10.1038/sj.leu.2402728 · Cited by 12
Role of the NF1 Gene in Leukemogenesis and Myeloid Growth Control
O'Marcaigh, A. S., & Shannon, K. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199711000-00015 · Cited by 12
Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells
Longoni, D. V., D’Amico, G., Gaipa, G., Bernasconi, S., Vulcano, M., Onnis, P., Niemeyer, C. M., Allavena, P., & Biondi, A. (2002) · The Hematology Journal · doi:10.1038/sj.thj.6200192 · Cited by 11
Murine tumor suppressor models
Venkatachalam, S., & Donehower, L. A. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00018-9 · Cited by 11
Increased c‐Myc activity and DNA damage in hematopoietic progenitors precede myeloproliferative disease in Spa‐1‐deficiency
Tanaka, H., Tamura, A., Sekai, M., Hamazaki, Y., & Minato, N. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01850.x · Cited by 10
Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1
Rhodes, S. D., & Yang, F. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0298-z · Cited by 10
Cytogenetic and Molecular Genetic Aspects of Childhood Myeloproliferative/Myelodysplastic Disorders
Hall, G. W. (2002) · Acta Haematologica · doi:10.1159/000065654 · Cited by 10
Pancytopenia presenting with monosomy 7 which disappeared after immunosuppressive therapy
Nagasawa, M., Tomizawa, D., Tsuji, Y., Kajiwara, M., Morio, T., Nonoyama, S., Asada, M., & Mizutani, S. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00263-7 · Cited by 10
Myeloid Leukemia, Myelodysplasia, and Myeloproliferative Disease in Children
Clark, J., Berman, J. N., & Look, A. T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00011-x · Cited by 9
Therapy-Related Myelodysplastic Syndrome in Adults with Neurofibromatosis
Papageorgio, C., Seiter, K. P., & Feldman, E. J. (1999) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199909058420 · Cited by 10
New pieces of a puzzle: The current biological picture of MPN
Kleppe, M., & Levine, R. L. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.07.002 · Cited by 9
Genetic Predispositions and Childhood Cancer
Shannon, K. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106801 · Cited by 9
Essential Thrombocythemia
Tefferi, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-34506-0_18 · Cited by 9
Transgenic mice as research tools in neurocarcinogenesis
Rovigatti, U., Afanasyeva, T., Brandner, S., Hainfellner, J. A., Kiess, M., Maddalena, A. S., Malin, G., Rülicke, T., Steinbach, J. P., Weissenberger, J., et al. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114516 · Cited by 9
Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia
Stirewalt, D. L., & Radich, J. P. (2000) · Hematology · doi:10.1080/10245332.2000.11746484 · Cited by 9
Deficiency of β Common Receptor Moderately Attenuates the Progression of Myeloproliferative Neoplasm in Nras/+ Mice
Zhang, J., Ranheim, E. A., Du, J., Liu, Y., Wang, J., Kong, G., & Zhang, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.653154 · Cited by 8
Ras-Gefs and Ras Gaps
Rojas, J. M., & Santos, E. (2006) · Springer eBooks · doi:10.1007/1-4020-4708-8_2 · Cited by 8
Mixed myeloproliferative and myelodysplastic disorders
Emanuel, P. D. (2007) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-007-0002-6 · Cited by 8
Translocation (6;17)(q23;q11.2): a novel cytogenetic abnormality in congenital acute myeloid leukemia?
Ferguson, E. C., Talley, P. J., & Vora, A. J. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.03.016 · Cited by 8
RAS Inhibitors in Hematologic Cancers: Biologic Considerations and Clinical Applications
Beaupre, D. M., & Kurzrock, R. (1999) · Investigational New Drugs · doi:10.1023/a:1006319116226 · Cited by 8
Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice
Tarnawsky, S. P., Yu, W., Qu, C., Chan, R. J., & Yöder, M. C. (2018) · Oncotarget · doi:10.18632/oncotarget.25073 · Cited by 8
Tumor Suppressor Gene Regulation of Cell Growth: Recent Insights into Neurofibromatosis 1 and 2 Gene Function
Uhlmann, E. J., & Gutmann, D. H. (2001) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:34:1:61 · Cited by 8
Neurofibromatosis: the role of guanosine triphosphatase activating proteins in sensory neuron function.
Hingtgen, C. M. (2008) · PubMed · Cited by 7
Inhibition of farnesyltransferase: A rational approach to treat cancer?
Puntambekar, D. S., Giridhar, R., & Yadav, M. R. (2007) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360601072841 · Cited by 7
Germline Neurofibromin 1 mutation enhances the anti‐tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity
Wang, W., Li, X., Qin, X., Miao, Y., Zhang, Y., Li, S., Yao, R., Yang, Y., Yu, L., Zhu, H., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.18851 · Cited by 6
Myeloproliferative and “Overlap” Myelodysplastic/Myeloproliferative Neoplasms
Thakral, B., Anastasi, J., & Wang, S. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47913-4.00017-3 · Cited by 6
Principles of Genetics, Mosaicism and Molecular Biology
Happle, R. (2011) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781444345384.ch115 · Cited by 6
10 Childhood myeloproliferative disorders
Cotter, F. E. (1998) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(98)80044-9 · Cited by 5
Acute Myeloid Leukemia Associated With t(8;21) or Trisomy 8 in Children With Neurofibromatosis, Type 1
Kratz, C. P., Antonietti, L., Shannon, K., Dole, M. G., & Friebert, S. E. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200304000-00018 · Cited by 5
Mouse Models of CMML
Belotserkovskaya, E., & Demidov, O. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111510 · Cited by 5
Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia
Haeri, M., Li, Y., Li, Y., Li, Q., Spaner, D., & Ben‐David, Y. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1943 · Cited by 5
Skin-Derived Precursor Cells as an In Vitro Modelling Tool for the Study of Type 1 Neurofibromatosis
Gutiérrez‐Rivera, A., Iribar, H., Tuneu, A., & Izeta, A. (2012) · Stem Cells International · doi:10.1155/2012/646725 · Cited by 5
Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype
Wiesner, S. M., Geurts, J. L., Diers, M. D., Bergerson, R. J., Hasz, D. E., Morgan, K. J., & Largaespada, D. A. (2011) · American Journal of Hematology · doi:10.1002/ajh.22035 · Cited by 5
Self-citation
Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes
Pogam, C. L., Krief, P., Beurlet, S., Soulié, A., Balitrand, N., Cassinat, B., Cavé, H., Kosmider, O., Setterblad, N., Lebœuf, C., et al. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.10.018 · Cited by 5
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis
Rhodes, S. D., Yang, H., Dong, R., Menon, K., He, Y., Li, Z., Shi, C., Staser, K. W., Jiang, L., Wu, X., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2538 · Cited by 6
Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome?
Fareez, F., Wang, B. H., Brain, I., & Lu, J. (2023) · Pathology · doi:10.1016/j.pathol.2023.01.002 · Cited by 4
Neurofibromatosis type I
Darken, R. S., & Gutmann, D. H. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.061 · Cited by 4
Cell signaling defects and human disease.
Mora-Garcia, P., & Sakamoto, K. M. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2798 · Cited by 4
Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive RasPreprint
Wandler, A. M., & Shannon, K. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031526 · Cited by 4
Chronic myeloproliferative disorders
Niemeyer, C. M., & Locatelli, F. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.020 · Cited by 3
Neurofibromatosis Type I: From Genetic Mutation to Tumor Formation
Thomas, S. L., & Vries, G. H. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_6 · Cited by 3
Heritable predispositions to childhood hematologic malignancies
Le, D., Shannon, K., & Lange, B. J. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.014 · Cited by 3
Juvenile Myelomonocytic Leukemia
&NA; (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00002 · Cited by 3
A tyrosine kinase protein interaction map reveals targetable EGFR network oncogenesis in lung cancerPreprint
Kaushik, S., Haderk, F., Zhao, X., Hu, H., Shah, K. N., Jang, G. Μ., Olivas, V. R., Nanjo, S., Jascur, J., Masto, V. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.02.185173 · Cited by 3
Growth Factor Signaling in Polycythemia Vera Cells: Specific Hypersensitivities to Cytokines in the Chronic Myeloproliferative Disorders
Axelrad, A. A. (2004) · Springer eBooks · doi:10.1007/978-3-642-18738-4_8 · Cited by 3
Novel humanized loss-of-function NF1 mouse model of juvenile myelomonocytic leukemia
Sinha, R., Patil, R. V., Romano, R., Sharma, D., Lee, E., Perriman, R., Takeda, S., Lesch, B. J., Yao, Z., Liu, Y. L., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015191 · Cited by 2
NF1 Mutations in Hematologic Cancers
Chang, T. Y., & Shannon, K. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_30 · Cited by 2
Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia (JMML)
Lauchle, J., & Braun, B. S. (2010) · Springer eBooks · doi:10.1007/978-0-387-69062-9_7 · Cited by 2
Neurofibromatosen
Krone, W., & Kehrer‐Sawatzki, H. (2001) · Springer eBooks · doi:10.1007/978-3-642-56889-3_6 · Cited by 2
Clinical manifestations associated with the aberrant expression of the soluble granulocyte–macrophage colony‐stimulating factor receptor in patients presenting with haematological malignancies
Trus, M., Bordeleau, L. J., Pihl, C. E., McGeer, A., Prevost, J. M., Minden, M. D., & Brown, C. B. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04235.x · Cited by 2
Myeloid Malignancies
Kogan, S. C. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc013 · Cited by 2
In Vitro Regulation of Colony Stimulating Factor-Mediated Hematopoiesis in Healthy Individuals and Patients with Different Types of Myeloproliferative Disease
Vraetz, T., Emanuel, P. D., & Niemeyer, C. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-345-3:293 · Cited by 1
Myelodysplastic/myeloproliferative neoplasms
Choi, J. K. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781292.014 · Cited by 1
Immune system changes in the pathogenesis of neurofibromatosis type 1
Mustafin, R. N. (2022) · Oncohematology · doi:10.17650/1818-8346-2022-17-1-113-120 · Cited by 1
Clinicopathologic characteristics of de novo NF1 -mutated acute myeloid leukemia
Zhang, B., Mahsoub, S., Weinberg, O. K., & Germans, S. K. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2382329 · Cited by 1
Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia
Fu, S., Guo, Y., Peng, Z., Zhang, D., Chang, Z., Xiao, Y., Zhang, Q., Yu, L., Chen, C., Chen, Y., et al. (2024) · Medical Oncology · doi:10.1007/s12032-024-02549-5 · Cited by 1
Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation
Pundavela, J., Hall, A., Dinglasan, S. A., Choi, K., Rizvi, T. A., Trapnell, B. C., Wu, J., & Ratner, N. (2025) · Cancers · doi:10.3390/cancers17050905 · Cited by 1
Myelodysplastic Syndromes and Myeloproliferative Neoplasms in Children
Smith, F. O., Dvorak, C. C., & Braun, B. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00063-9 · Cited by 1
Neurofibromatosis: Type I
Viskochil, D. H. (2006) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0005534 · Cited by 1
Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia
Krance, R. A. (2003) · doi:10.1002/9780470987070.ch74 · Cited by 1
Neurofibromatosis Type I ( NF 1)
Viskochil, D. H. (2009) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0005534.pub2 · Cited by 1
Neurofibromatoses
Bernards, A., & McClatchey, A. I. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_11 · Cited by 1
Animal Models of Hematopoietic Growth Factor Perturbations in Physiology and Pathology
Lieschke, G. J. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-747-5_2
Drug Response and Resistance in Advanced NF1-Associated Cancers
Shannon, K. (2013) · doi:10.21236/ada581891
Neurofibromin and IL-4 as Regulators of T Cell Development, Function, and Homeostasis
Oliver, J. A. (2012) · Deep Blue (University of Michigan)
Dissecting Neurofibromatosis Type 1 Related Vasculopathy
Lasater, E. A. (2010) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1788
Juvenile chronic myelogenous leukemia (JCML)
Hess, J. L. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/37702
Retroviral Insertional Mutagenesis in Mouse Models of Leukemia and Lymphoma
Largaespada, D. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7656-7_2
Self-citation
NEUROFIBROMIN, NERVE GROWTH FACTOR AND RAS: THEIR ROLES IN CONTROLLING THE EXCITABILITY OF MOUSE SENSORY NEURONS
Wang, Y. (2007) · IUScholarWorks (Indiana University) · doi:10.7912/c2/279
the t(8;21) Fusion Protein Neurofibromatosis-1 Tumor Suppressor by Transcriptional Repression of the
Hiebert, S. W., Gutmann, D. H., Delwel, R., Clapp, D. W., Gao, M., Khalaf, W. F., & van de Locht, L. T. (2014)
to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions
Yang, F., Shi, C., Robling, A. G., Yu, X., Nebesio, T. D., Yan, J., Morgan, T., Li, X., Yuan, J., Hock, J. M., et al. (2006)
Mediated by Ras Inhibition of Myeloid Differentiation Ral Is both Necessary and Sufficient for the
Darley, L., Omidvar, N., Pearn, L., Burnett, A. K., & Richárd (2014)
Transcription factors in hematopoietic differentiation and leukemia
Chapman, M. A., & Green, A. R. (2010) · Taylor & Francis eBooks · doi:10.4324/9780203339886_chapter_5
Interference with signaling pathways in malignant disease
Khwaja, A. (2004) · CRC Press eBooks · doi:10.1201/b14440-28
Short title - Mast cells and the neurofibroma microenvironment
Staser, K. W., Yang, F., & Clapp, D. W. (2016)
Leukozytose
Sliwa, T., & Geissler, K. H. (2008) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-008-0035-3
Myelodysplastic Syndromes
Webb, D. K. H. (2006) · doi:10.1002/9780470987001.ch18
In Vitro Regulation of Colony Stimulating Factor-Mediated Hematopoiesis in Healthy Individuals and Patients with Different Types of Myeloproliferative Disease
Vraetz, T., Emanuel, P. D., & Niemeyer, C. M. (2003) · Methods in molecular biology · doi:10.1007/978-1-59259-345-3_22
NF1, NF2
Hesketh, R. (1997) · Elsevier eBooks · doi:10.1016/b978-012344548-3/50084-4
Neurofibromatosis
Claudio, J. O., & Rouleau, G. A. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_106
Transcription factors in hematopoietic differentiation and leukemia
Chapman, M., & Green, A. R. (2004) · CRC Press eBooks · doi:10.1201/b14440-6
THE ROLE OF PAK1 IN THE CELLULAR AND MOLECULAR COMPONENTS OF PLEXIFORM NEUROFIBROMAS
McDaniel, A. S. (2008) · doi:10.7912/c2/1684
Caractérisation moléculaire et étude des conséquences fonctionnelles des mutations somatiques du gène NF1 dans les carcinomes bronchiques non à petites cellules
Tlemsani, C. (2018) · theses.fr (ABES) · doi:10.70675/8f53e2e3z34d1z4c4bz80cfz5afce9d3ade3
Insights towards a better understanding and novel treatment modalities of Toxoplasmosis
Hamie, M. (2019) · theses.fr (ABES) · doi:10.70675/b72379f2zcf9fz414dz9c9fzc0810b02d5e3

Authors: Largaespada, D. A., Brannan, C. I., Jenkins, N. A., & Copeland, N. G.
Affiliations: Frederick National Laboratory for Cancer Research (US)
University of Florida (US)
ORCID: Largaespada, David A.
Jenkins, Nancy A.
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1996-02
Volume: 12
Issue: 2
Pages: 137-143
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0296-137
OpenAlex: W2087533846
Cited by: 284
References: 33
Citations by year: 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 14
FWCI: 15.71
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords: neurofibromatosis type 1, NF1 deficiency, Ras signaling, GM-CSF, GM-CSF hypersensitivity, chronic myeloid leukemia, myeloproliferative neoplasms, hematopoietic stem cells, genetic screen, Ras GTPase-activating protein
MeSH terms: Acute Disease, Animals, Bone Marrow, Cell Differentiation, Cell Line, Transformed, Crosses, Genetic, Disease Models, Animal, Female, Guanosine Triphosphate, Hematopoietic Stem Cells, Humans, Leukemia, Myeloid, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Granulocyte-Macrophage Colony-Stimulating Factor, Genes, Neurofibromatosis 1, Hematopoietic Stem Cell Transplantation, Disease Progression, ras Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nf1 deficiency causes Ras-Dediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks